IMU 2.04% 4.8¢ imugene limited

Media Thread, page-6057

  1. 1,392 Posts.
    lightbulb Created with Sketch. 10629
    Thanks mate, someone posted it earlier on a different thread but can't find it. I'm always happy to see these things in the media thread.
    Some tasty info in this to add to the picture, a few points I picked out:
    • CheckVacc about to clear cohort 2.
    • CheckVacc has 8(?) cohorts for dose escalation
    • Hervaxx patient up to 900 days survival
    • Pd1Vaxx patient now at 18-19 months cancer free
    • Lots of preclinical data coming from Celularity and Eureka for Oncarlytics
    • Re Hervaxx: 4 patients remain on the Hervaxx arm. 0 remain on chemo arm

    https://hotcopper.com.au/data/attachments/4486/4486918-8dad24eb7d5089b60f55716f8eaa7a9f.jpg

    https://hotcopper.com.au/data/attachments/4486/4486923-e8a3e09299d364cd153c29d46e7809b2.jpg
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.